EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Improved Synthesis Route of Molnupiravir and its Key Impurities

Guojing Li, Zhihao Du, Xin Gao, Dongsheng Chen, Yu Liu

Pharmaceutical Fronts · 01.12.2025 · 07 (04) · e357-e362

DOI: 10.1055/a-2735-5050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Fronts, erschienen am 01.12.2025. Verfasst von Guojing Li und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Science and Technology Commission, China State Institute of Pharmaceutical Industry Co., Ltd..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This paper aims to improve the synthetic process of molnupiravir based on previously reported synthetic routes. The route begins with uracil (ML-2), which is protected with an isopropyl group to yield ML-3 (Step 1), followed by an esterification and a triazolation reaction (Steps 2 and 3) to produce ML-5, which, via a hydroxylation reaction and deprotection (Steps 4 and 5), gives the target product ML-1. Nuclear magnetic resonance (1H NMR) and mass spectra were used for chemical structure identification. There are mainly the following improvements, including: (1) replacing the separate addition of acetone and concentrated H2SO4 with 2,2-dimethoxypropane and catalytic p-toluenesulfonic acid monohydrate in Step 1, simplifying the workup operation and reducing the dosage of reaction solvent. (2) Optimize the synthesis conditions of ML-5, reduce the formation of impurities, and improve the purity of the crude product from 43.12 to 85.21%. (3) Three impurities were isolated, two of which are new compounds. This article lays a foundation to obtain molnupiravir with controllable quality and a stable process for the treatment of coronavirus disease 2019.

Förderung

  • Shanghai Science and Technology Commission
  • China State Institute of Pharmaceutical Industry Co., Ltd.

Zitieren

APA

Li, G., Du, Z., Gao, X., Chen, D., & Liu, Y. (2025). An Improved Synthesis Route of Molnupiravir and its Key Impurities. Pharmaceutical Fronts, 07(04), e357-e362. https://doi.org/10.1055/a-2735-5050

Vancouver

Li G, Du Z, Gao X, Chen D, Liu Y. An Improved Synthesis Route of Molnupiravir and its Key Impurities. Pharmaceutical Fronts. 2025;07(04):e357-e362. doi:10.1055/a-2735-5050

BibTeX
@article{Li2025,
  author = {Li, Guojing and Du, Zhihao and Gao, Xin and Chen, Dongsheng and Liu, Yu},
  title = {An Improved Synthesis Route of Molnupiravir and its Key Impurities},
  journal = {Pharmaceutical Fronts},
  year = {2025},
  volume = {07},
  number = {04},
  pages = {e357--e362},
  doi = {10.1055/a-2735-5050}
}
Kostenlos starten →